Bumrungrad Hospital

New Cancer Center And Robotic Surgery Will Expand Global Capacity

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

12 Dec 24

Updated

13 Nov 25

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

-18.5%

7D

-1.2%

Loading

1Y

-18.5%

7D

-1.2%

You can edit this narrative until Nov 14 2:10 PM. Then, changes will post as Updates.

Author's Valuation

฿214.6221.0% undervalued

AnalystConsensusTarget Fair Value

Shared on 13 Nov 25

Fair value Increased 2.27%

BH: Revenue Outlook Will Drive Attractive Upside Potential Ahead

Bumrungrad Hospital Price Target Raised on Growth Outlook Analysts have increased their fair value estimate for Bumrungrad Hospital from 209.86 THB to 214.62 THB, citing improved revenue growth projections. This comes despite a slightly higher discount rate and lower profit margin expectations.

Shared on 07 Aug 25

Fair value Increased 0.66%

The top metrics for Bumrungrad Hospital—future P/E and consensus revenue growth—remained essentially flat, supporting a marginal increase in the analyst price target to THB209.00. Valuation Changes Summary of Valuation Changes for Bumrungrad Hospital The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from THB208.48 to THB209.00.

Shared on 01 May 25

Fair value Decreased 10%

Shared on 23 Apr 25

Fair value Decreased 1.12%

AnalystConsensusTarget has increased revenue growth from 3.2% to 5.2%.

Shared on 17 Apr 25

Fair value Decreased 1.88%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Fair value Decreased 1.60%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Decreased 1.40%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Increased 23%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 12 Mar 25

Fair value Decreased 6.59%

AnalystConsensusTarget Fair Value

฿214.62

21.0% undervalued

Future estimation in

% p.a.

0

Decrease

Increase

Current revenue growth rate

5.67%

Healthcare Services revenue growth rate

0.22%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

7.44%

Calculation

฿8.08b

Earnings '28

x

26.19x

PE Ratio '28

=

฿211.59b

Market Cap '28

฿211.59b

Market Cap '28

/

795.11m

No. shares '28

=

฿266.11

Share Price '28

฿266.11 Share Price '28

Discounted to 2025 @ 7.44% p.a.

=

฿214.59

Fair Value '25